Literature DB >> 7074094

Noncovalent inhibitors of sickle hemoglobin gelation: effects of aryl-substituted alanines.

W N Poillon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7074094     DOI： 10.1021/bi00535a046

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  6 in total

1.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

Authors:  W N Poillon; B C Kim; G P Rodgers; C T Noguchi; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 2.  Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

Authors:  Piyusha P Pagare; Aref Rastegar; Osheiza Abdulmalik; Abdelsattar M Omar; Yan Zhang; Andrew Fleischman; Martin K Safo
Journal:  Expert Opin Ther Pat       Date:  2021-11-01       Impact factor: 6.714

3.  Photoaffinity labelling of cyanomethaemoglobin with derivatives of tryptophan and 5-bromotryptophan.

Authors:  M Li; Z Lin; M E Johnson
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

4.  Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.

Authors:  J R Votano; J Altman; M Wilchek; M Gorecki; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Authors:  Adrienne Tin; Girish Nadkarni; Anne M Evans; Cheryl A Winkler; Erwin Bottinger; Casey M Rebholz; Mark J Sarnak; Lesley A Inker; Andrew S Levey; Michael S Lipkowitz; Lawrence J Appel; Dan E Arking; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2018-05-18       Impact factor: 10.121

Review 6.  Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease.

Authors:  Olujide O Olubiyi; Maryam O Olagunju; Birgit Strodel
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.